Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
VectorBuilder
AddedFeb 13, 2024
UpdatedJun 18, 2026
VectorBuilder

VectorBuilder

Late Stage Private

VectorBuilder: Online platform for vector cloning, gene delivery solutions, and CRO services.

HQ
Chicago, IL, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize gene delivery and vector cloning, VectorBuilder offers an online platform specializing in the design, development, and optimization of gene delivery solutions. Their services include scientific research vector customization and clinical vector preparation, catering to both basic scientific research and drug development. VectorBuilder's market focus spans across academia, biotechnology, and pharmaceutical industries, providing personalized vector and virus packaging solutions.

VectorBuilder has garnered attention from notable investors and industry leaders due to its innovative approach and comprehensive service offerings. The company has achieved significant milestones in advancing gene delivery technologies, contributing to numerous scientific breakthroughs and drug development projects. Its impact is evident in the widespread adoption of its platform by researchers and institutions globally, solidifying its position as a leader in the gene delivery and vector cloning sector.

VectorBuilder - Similar Companies

Vector Laboratories logo

Vector Laboratories

vectorlabs.com

PackGene Biotech logo

PackGene Biotech

packgene.com

Vector Biomed logo

Vector Biomed

vectorbiomed.com

VintaBio logo

VintaBio

vintabio.com

MedVector logo

MedVector

medvector.com

BioRender logo

BioRender

biorender.com

Vector Vitale logo

Vector Vitale

vectorvitale.com

Health Vector logo

Health Vector

healthvector.world

Benchling logo

Benchling

benchling.com

Genemod logo

Genemod

genemod.net

64x Bio logo

64x Bio

64xbio.com

VectorCare logo

VectorCare

vectorcare.com

Vectr logo

Vectr

vectr.com

AmplifyBio logo

AmplifyBio

nVector logo

nVector

nvector.com

VectorBuilder - Quick Facts

Who are VectorBuilder's competitors?

Companies similar to VectorBuilder include Vector Laboratories, PackGene Biotech, Vector Biomed and VintaBio.

When was VectorBuilder founded?

VectorBuilder was founded in 2015.

Where is VectorBuilder's headquarters located?

VectorBuilder's headquarters is located in Chicago, IL, US.

How much has VectorBuilder raised to-date?

As of May 23, 2023, VectorBuilder has raised a total of $410M (USD).

How many employees does VectorBuilder have?

VectorBuilder has 375 employees as of Feb 4, 2024.

VectorBuilder - Classification

Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Small Business
Main Product
  • Gene Delivery
  • Vector Cloning
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software